Being a mathematician and chemical engineer by profession Stefan is involved in pharmaceutical serialization since its early days in 2008 and renowned as one of the fathers of the European ‘Point-of-Dispense Verification’ model that ensures patients’ access to safe medicines.
For more than seven years Stefan worked as a delegate consultant for the European Federation of Pharmaceutical Industries and Associations (EFPIA) where he contributed to the successful verification pilot in Sweden in 2009 / 2010 and played a key role in the design and development of the European Medicines Verification System (EMVS) that constitutes a key component in the implementation of the EU Falsified Medicines Directive (FMD).
Once having returned from Brussels Stefan led Bayer’s activities to implement the Brazilian Track&Trace requirements in 2014 and 2015 before his focus shifted back to the roots as the responsible program manager for the timely FMD readiness of Bayer’s Pharmaceuticals and Consumer Health divisions by February 2019. Currently, he manages Bayer’s rollout of Track&Trace for Brazil that was restarted by ANVISA in 2020.
Beyond his project assignments Stefan Artlich engages on a strategic level for supply chain improvements ensuring patients’ safety and uninterrupted access to medicines. As an example, he serves since 2016 as an elected member of the GS1 Healthcare Leadership Team that steers GS1 Healthcare’s activities for the integration of GS1 standards into the supply chain processes of the healthcare sector in order to drive patient safety and supply chain efficiency improvements not only in the private but as well in the public sector.

Bayer is a Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time. A growing and aging world population requires an adequate supply of food and improved medical care. With life expectancy continuing to rise, we improve quality of life for a growing population by focusing our research and development activities on preventing, alleviating and treating diseases. We are also making an important contribution to providing a reliable supply of high-quality food, feed and plant-based raw materials.